Blood Screening (Nucleic Acid Amplification Test, ELISA, Rapid Test) Market Worth $2.5 Billion by 2019
According to a new market research report "Blood Screening Market by Technology (Nucleic Acid Amplification Test, ELISA, Rapid Test, Chemiluminescence Immunoassay, Next Generation Sequencing, Western Blotting), Product (Instrument, Reagent) & End User (Blood Bank, Hospital) - Forecasts to 2019", published by MarketsandMarkets, provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Blood Screening Market along with estimates and forecasts of the revenue and share analysis.
View full press release